These data showed that the combination treatment with CHI3L1 siRNA and ebractenoid F induced a synergistic effect and indicated that CHI3L1 plays a major role in the ebractenoid F-induced inhibitory effects on cancer cell growth and migration, as well as in the induction of cell apoptosis. Here, CHI3L1 is linked to cancer.